When a booster vaccine was administered in the same location as the initial dose, the mice's subcapsular sinus macrophages were already primed. They reactivated immune cells called memory B cells more quickly.
"Therapies aimed at improving mitochondrial activity could benefit inflammatory diseases such as inflammatory bowel disease, sepsis, and chronic infections by enhancing the immune system's ability to regulate inflammation."